Sponsored Links
| Advanced Accelerator Applications Receives GMP Approval To Manufacture Lutate For Treatment Of NeuroEndocrine Tumors |
 |
 |
 |
| Medical News - Endocrinology | |||
|
Advanced Accelerator Applications (AAA), an emerging international leader in molecular nuclear medicine, announced that it has received GMP (Good Manufacturing Practice) approval for the manufacture of Lutate, a radioactively labelled peptide that can be used to treat metastatic GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs)... Read more: Endocrinology News From Medical News Today
|